Preparation of Lymphokines. Lymphokines were prepared by culturing the spleen cells of Listeria monocytogenes-chailenged mice in the presence of concanavalin A for 24 h according to a method modified from that of Havell et al. (4) . Briefly, C57BL/6J mice (8-15 wk old) were inoculated intravenously with 0.1 ml of saline that contained 1 × 103
Listeria monocytogenes. 7 d later, spleen cells were cultured at a concentration of 1 × 107 cells/ml in serum-free RPMI 1640 medium to which 2 /Lg/ml concanavalin A (Sigma Chemical Co., St. Louis, MO) had been added. Seven lymphokine preparations made according to this procedure contained 4,127-9,010 IU of interferon/ml (~ = 6,953).
Interferon Assay. A cytopathic effect inhibition assay modified from that of Haveil and Vilcek (5) as described previously (3) was used for measuring IFN. IFN activity was calibrated against a World Health Organization international reference preparation of mouse type I IFN (G-002-904-511) (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD) and is expressed as international units.
Treatment of Cells with Cloned IFN-% Infection of Cells with Rickettsiae, and Measurement of Rickettsial Growth.
Methods for x irradiation of cells, infection of cells, and measurement of rickettsial growth have been detailed previously (1). After x irradiation, L929 cells or human foreskin fibroblasts were adjusted to a density of 1.2 × 105 viable ceils]ml, planted in eight-chambered slides (0.3 ml/chamber) (Lab-Tek Div., Miles Laboratories, Inc., Naperviile, IL), and incubated overnight. The culture medium was then removed and the cells were treated for 24 h with medium alone or with medium that contained cloned IFN-~ or CM. Then, after the cells were infected with rickettsiae and washed, medium alone or medium that contained cloned IFN-~, or CM was added. Infected cells were incubated at 34°C for up to 48 h. At 0, 24, and 48 h after infection, slides were dried, fixed, and stained by a modification of the Gimenez method, as previously described (1). Slides were examined microscopically with an oil immersion objective and the number of rickettsiae present in each of 100 cells was counted for each duplicate of each experimental treatment. When a cell contained >100 rickettsiae, it was assigned a value of 100; this practice causes an underestimate of the number of rickettsiae at later times. The percentage of cells infected with rickettsiae (%R), the average number of rickettsiae per infected cell (RI), and the average number of rickettsiae per cell (NR) were determined. The data were normalized to the zero time infection; e.g., RI at a given time divided by RI at 0 h multiplied by 100 gives the average number of rickettsiae per infected cell as a percentage of that observed at 0 h.
Comparison of the Effect of Cloned IFN-'y and Crude Mouse Lymphokines on Rickettsial
Growth. Dilutions of IFN-'r or crude mouse lymphokines were made in eight-chambered Lab-Tek slides (150 #l/chamber). A suspension of irradiated L929 cells was infected with R. prowazekii, and washed, and 3.8 × 104 cells in 150 #1 of tissue culture medium were added per chamber. Samples of the infected cell suspension were immediately cytocentrifuged onto microscope slides, dried, fixed, and stained. After incubation at 34°C for 48 h, the chamber slides were also dried, fixed, and stained. Percent inhibition of rickettsial growth in the treated chambers was calculated from the values of NR at 48 h after infection (expressed as percentages of the values of NR observed at 0 h). At the time of each experiment, the IFN-~, and crude lymphokines were assayed for IFN.
Results

AIM of Cloned Mouse IFN-7.
During the 48-h period after infection, dramatic effects on both %R and RI were observed in R. prowazekii-infected L929 cell cultures that were treated with cloned mouse IFN-7 both 2't h before and after infection (Fig. 1) . Only 63% of the L929 cells that were infected at 0 h remained infected at 48 h after infection in these IFN-'r-treated cultures (%R). In contrast, in control cultures or in cultures treated with CM both before and after infection, all of the cells that were infected at 0 h remained infected at 48 h. RI underwent little change in these IFN-~r-treated cultures during the 48 h period after infection; thus, rickettsial growth was almost completely inhibited in the IFN-ytreated cells that remained infected with rickettsiae. In contrast, rickettsial growth occurred in the control and CM-treated cultures: RI increased "~ 15-fold in the former and 9-fold in the latter. Less dramatic ARA was observed when L929 cells were treated with cloned mouse IFN-3" either only before or only after infection with R. prowazekii (Fig.   1 ). In these cultures, rickettsial growth was markedly inhibited, but most of the cells that were infected with rickettsiae at 0 h remained infected at 48 h after infection. In cultures treated with IFN-3" only after infection, there was complete inhibition of rickettsial growth between 24 and 48 h after infection but inhibition was minimal or absent between 0 and 24 h after infection. 
Cycloheximide Suppression and Species Specificity of the ARA of Cloned Mouse IFN-
Comparison of the ARA of Cloned Mouse IFN-~ and Crude Mouse Lymphokines. Marked inhibition of rickettsial growth was apparent in chambers that
contained as few as 5 IU of IFN as cloned mouse IFN-7 or crude mouse lymphokines (Fig. 2) . Cloned mouse IFN-~' produced by either Chinese hamster ovary cells or E. coli had identical dose-response curves. The percent inhibition of rickettsial growth in cultures treated with various concentrations of crude mouse lymphokines plateaued at a slightly higher value (~-90%) than that observed in cultures treated with various concentrations of cloned mouse IFN-~ ('~-80%). Most of the ARA of the crude iymphokines can be accounted for by the IFN-~ that is present in the crude lympokines. However, some other minor antirickettsial factor(s) may also be present in the crude lymphokines.
Discussion
The effects of cloned mouse IFN-~ on the survival and growth of R. prowazekii in mouse fibroblasts were similar to the effects of crude mouse lymphokines (1). In mouse L929 cells treated with either material 24 h before and after infection, the rickettsiae were cleared from some of the infected cells and rickettsial growth was suppressed in the cells that remained infected. Time was required for the establishment of antirickettsial conditions within L929 cells by either material because rickettsial growth was more strongly inhibited during the first 24 h after infection in cells pretreated for 24 h than in cells treated only after infection. Continued expression of the antirickettsial conditions induced by either material may require the continued presence of the material since the antirickettsial effects observed in cells treated before and after infection were more pronounced than those observed in cells treated only before infection. Induction of antirickettsial conditions by either material was suppressed by cycloheximide, and neither the cloned mouse IFN-3, nor the crude mouse lymphokines induced antirickettsial conditions in human foreskin fibroblasts.
Our previous work indicated that ARA and IFN--y have several characteristics in common (1, 3) . We have shown here that cloned mouse IFN-3, induces antirickettsiai conditions in mouse fibroblasts. Inhibition of the growth of a protozoan parasite, Toxoplasma gondii, within human fibroblasts treated with cloned human IFN-3, was recently reported (6). Thus, IFN-'r can induce antimicrobial activity against either prokaryotic or elJkaryotic microorganisms that grow within nonprofessional phagocytes.
The effectiveness of IFN-3, against R. prowazekii in vivo remains to be determined, but we speculate that production of IFN-3, by sensitized T lymphocytes may explain (in large part) the protective effect of adoptively transferred T lymphocytes or unfractionated spleen cells from immune animals against various rickettsial infections in animals (7) (8) (9) (10) (11) . Production of IFN-3, has been demonstrated in immunized mice after challenge with viable R. tsutsugamushi (12) 
Summary
The effect of treating cultured mouse fibroblasts (L929 cells) with cloned mouse interferon-3, on the growth of Rickettsia prowazekii within the fibroblasts was studied. Within 48 h after infection, rickettsiae were cleared from a substantial proportion of the initially infected cells and rickettsial growth was inhibited in those cells that remained infected, when L929 cells were treated with cloned mouse interferon-3, both before and after infection. When L929 cells were treated with cloned mouse interferon-7 either only before or only after infection with rickettsiae, rickettsial growth was markedly inhibited but rickettsiae were not cleared from many cells. Addition of cycloheximide to L929 cells markedly suppressed the antirickettsial activity of the interferon, and cloned mouse interfi~ron-3, did not induce antirickettsial activity in human foreskin fibroblasts. The antirickettsial effects of cloned mouse inteferon-3, were similar to those induced by crude mouse lymphokines prepared from concanavalin A-stimulated mouse spleen cells. Equivalent amounts (units) of cloned mouse interferon-7 produced by Chinese hamster ovary cells or by Escherichia coli caused equivalent inhibition of rickettsial growth in mouse fibroblasts. However, at high concentrations of interferon-7, treatment of rickettsia-infected fibroblasts with equivalent amounts (units) of interferon-7, as crude mouse lymphokines or cloned mouse interferon-7, resulted in slightly greater inhibition of rickettsial growth by the crude lymphokines. Most of the antirickettsial activity of crude mouse lymphokines can be explained by the interferon-7 that is present in these preparations. Interferon-7, by virtue of its ability to inhibit rickettsial growth and effect the clearance of rickettsiae from nonprofessional phagocytes, may play a crucial role in the elimination of rickettsiae from the infected host. 14 September 1983. 
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